New option available for Alzheimer’s patients as FDA approves expanded drug use

The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...

Alzheimer’s drugs slammed as ‘ineffective’ in major review, but critics push back

Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...